Exposure to secondhand smoke remains a significant yet preventable cause of respiratory illness worldwide. Individuals who do not smoke but are regularly around smokers inhale thousands of harmful chemicals, including carcinogens and irritants that affect airway and lung function. Infants and children are particularly vulnerable, with increased risks of asthma development, recurrent respiratory infections, and impaired lung growth. Adults exposed chronically face higher incidences of chronic obstructive pulmonary disease and cardiovascular complications, showing how passive exposure can be just as dangerous as direct smoking. Public spaces, homes, and workplaces continue to be environments where involuntary inhalation compromises long-term respiratory well-being.
Reducing the health burden of passive smoking requires a combination of public policy, healthcare intervention, and community awareness. Smoke-free laws in restaurants, offices, and public transport have demonstrated measurable reductions in hospitalizations for respiratory conditions, underscoring the role of legislation in protecting vulnerable groups. Healthcare providers also play a role by counseling patients about risks, identifying early symptoms linked to passive exposure, and advocating preventive strategies. The broader consequences of secondhand smoke health impacts extend into family and societal health, making education and enforcement programs critical. Integrating awareness campaigns with policy measures gradually reduces exposure and promotes healthier communities, breaking the cycle of involuntary smoke-related harm.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation